Explore the Heterogeneity of Glioblastoma Based on Genes Related to Glutamine Metabolism
Cancer Informatics · 2026-05 · 25
DOI: 10.1177/11769351261449032 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Informatics, online erschienen am 13.05.2026. Verfasst von Ling Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu Province, China. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objectives
To establish a glutamine metabolism (GM)-based classification for glioblastoma (GBM) and evaluate its prognostic and immunotherapeutic implications.
Methods
A total of 237 GBM patients from the Chinese Glioma Genome Atlas (CGGA) database were included as the training set, and 219 patients from the Gene Expression Omnibus (GEO) database served as the validation set. Consensus clustering was performed based on the expression profiles of 13 GM-associated genes to identify robust subgroups. Differences between clusters were analyzed using clinical indices, genomic and transcriptomic biomarkers. Tumor response to immune checkpoint inhibitors (ICIs) was predicted using the tumor immune dysfunction and exclusion (TIDE) algorithm, tumor microenvironment (TME) score, T cell inflammation score, and SubMap algorithm. A GM-based classifier was subsequently developed and validated.
Results
Consensus clustering of the training set revealed 2 distinct subgroups (cluster 1 and cluster 2) with significant prognostic differences; cluster 2 exhibited poorer overall survival. Immunotherapy response prediction indicated that cluster 2 had a lower likelihood of benefiting from ICIs. The newly developed GM-based classifier demonstrated high accuracy (AUC > 0.9) and maintained strong consistency with the original clustering in terms of subtype classification and immunotherapy prediction across both datasets.
Conclusion
This study establishes a robust classification system for GBM based on glutamine metabolism-related genes, which effectively stratifies patients into prognostic subgroups and predicts immunotherapy response. The GM-based classifier offers a valuable tool for guiding clinical prognosis and treatment decisions in GBM.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu Province, China.
- The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu Province, China.
- Suzhou Hospital of Traditional Medicine, Jiangsu Province, China.
- The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China.
- The Affiliated Suzhou Hospital of Nanjing Medical University, Jiangsu Province, China.
ORCID-Profile: Ling Wang
Zitieren
APA
Wang, L., Chen, T., Chen, J., Yang, Y., Sun, L., Gu, C., & Cao, C. (2026). Explore the Heterogeneity of Glioblastoma Based on Genes Related to Glutamine Metabolism. Cancer Informatics, 25. https://doi.org/10.1177/11769351261449032
Vancouver
Wang L, Chen T, Chen J, Yang Y, Sun L, Gu C, et al. Explore the Heterogeneity of Glioblastoma Based on Genes Related to Glutamine Metabolism. Cancer Informatics. 2026;25. doi:10.1177/11769351261449032
BibTeX
@article{Wang2026,
author = {Wang, Ling and Chen, Tong and Chen, Jiajia and Yang, Yiwen and Sun, Linglin and Gu, Chao and Cao, Chenliang},
title = {Explore the Heterogeneity of Glioblastoma Based on Genes Related to Glutamine Metabolism},
journal = {Cancer Informatics},
year = {2026},
volume = {25},
doi = {10.1177/11769351261449032}
}
EUVIMED